Skip to Content
Merck
All Photos(8)

Key Documents

793558

Sigma-Aldrich

Sodium iodide

anhydrous, free-flowing, Redi-Dri, ReagentPlus®, ≥99%

Sign Into View Organizational & Contract Pricing


About This Item

Linear Formula:
NaI
CAS Number:
Molecular Weight:
149.89
EC Number:
MDL number:
UNSPSC Code:
12352302
PubChem Substance ID:
NACRES:
NA.21

grade

anhydrous

Quality Level

vapor density

>1 (vs air)

product line

ReagentPlus®
Redi-Dri

Assay

≥99%

form

powder

quality

free-flowing

impurities

≤1.0% water

pH

6-9 (20 °C, 50 g/L)

mp

661 °C (lit.)

SMILES string

[Na+].[I-]

InChI

1S/HI.Na/h1H;/q;+1/p-1

InChI key

FVAUCKIRQBBSSJ-UHFFFAOYSA-M

Looking for similar products? Visit Product Comparison Guide

General description

Sodium iodide is an inorganic sodium salt. It is used as an iodinating agent in organic synthesis to prepare various iodine-containing compounds. It is used in the conversion of alkyl halides and sulfonates into alkyl iodides and aryl iodides via nucleophilic displacement reactions. Additionally, sodium iodide is also used in combination with oxidizing agents for the iodination of organoboranes, phenols, and aromatic compounds.

Application

Sodium iodide can be used as an iodine precursor salt to synthesize semi-organic nonlinear optical single crystal of bis thiourea sodium iodide (BTSI) via slow evaporation solvent technique.

Legal Information

ReagentPlus is a registered trademark of Merck KGaA, Darmstadt, Germany
Redi-Dri is a trademark of Sigma-Aldrich Co. LLC

Pictograms

Exclamation mark

Signal Word

Warning

Hazard Statements

Hazard Classifications

Eye Irrit. 2

Storage Class Code

13 - Non Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Brian A Rabe et al.
Proceedings of the National Academy of Sciences of the United States of America, 117(39), 24450-24458 (2020-09-10)
The current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has had an enormous impact on society worldwide, threatening the lives and livelihoods of many. The effects will continue to grow and worsen if economies begin to open without the
P E N Braad et al.
Physics in medicine and biology, 60(13), 5297-5312 (2015-06-26)
Peri-therapeutic (124)I-PET/CT is of interest as guidance for radioiodine therapy. Unfortunately, image quality is complicated by dead time effects and increased random coincidence rates from high (131)I-activities. A series of phantom experiments with clinically relevant (124)I/(131)I-activities were performed on a
Anke de Vries et al.
Investigative radiology, 50(4), 297-304 (2015-01-01)
The objective of this study was to investigate the feasibility and the accuracy of spectral computed tomography (spectral CT) to determine the tissue concentrations and localization of high-attenuation, iodine-based contrast agents in mice. Iodine tissue concentrations determined with spectral CT
Mohamed Touati et al.
Leukemia & lymphoma, 56(2), 332-341 (2014-04-29)
Finding new prognostic factors to identify patients with Hodgkin lymphoma (HL) at risk of treatment resistance or relapse remains challenging in daily practice. We evaluated the relationship between CD68 expression, interim positron emission tomography (iPET) results and outcome in 158
Marlein Miranda Cona et al.
International journal of oncology, 44(3), 819-829 (2013-12-25)
Iodine-131‑labeled monoiodohypericin (131I‑Hyp) is a necrosis avid compound used as a complementary anticancer agent. Herein, the biodistribution in rats with re-perfused partial liver infarction (RPLI) was used to estimate its human internal radiation dosimetry. Iodine-123‑labeled monoiodohypericin (123I-Hyp) as a safer

Articles

Redi-Dri™ prevents hygroscopic powders, such as inorganic salts, from absorbing moisture and forming clumps, leaving the salts free-flowing every time.

Redi-Dri™ prevents hygroscopic powders, such as inorganic salts, from absorbing moisture and forming clumps, leaving the salts free-flowing every time.

Redi-Dri™ prevents hygroscopic powders, such as inorganic salts, from absorbing moisture and forming clumps, leaving the salts free-flowing every time.

Redi-Dri™ prevents hygroscopic powders, such as inorganic salts, from absorbing moisture and forming clumps, leaving the salts free-flowing every time.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service